Covid-19 pandemic and pregnancy.

Area of Science:

• Virology
• Obstetrics
• Public Health

Background:

• The emergence of COVID-19 (Coronavirus Disease 2019) caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) in late 2019 prompted global concern.
• SARS-CoV-2 shares characteristics with other beta-coronaviruses like SARS and MERS.
• The impact of SARS-CoV-2 on pregnant women and fetuses became a significant focus for obstetricians.

Purpose of the Study:

• To evaluate the current understanding of COVID-19's impact on pregnant women and fetal outcomes.
• To clarify the risks associated with SARS-CoV-2 infection during pregnancy.

Main Methods:

• Review of existing literature and clinical observations regarding COVID-19 in pregnancy.
• Analysis of reported outcomes including miscarriage, stillbirth, preterm labor, and teratogenicity.

Main Results:

• Current data suggests COVID-19 is not significantly more severe in pregnant women compared to the general population.
• COVID-19 infection during pregnancy has not been shown to increase rates of miscarriage, stillbirth, or preterm labor.
• Teratogenic effects of SARS-CoV-2 have not been established.

Conclusions:

• While direct adverse fetal outcomes appear uncommon, pregnant women remain susceptible to SARS-CoV-2 infection.
• Transmission of SARS-CoV-2 to pregnant women by asymptomatic carriers is possible.
• Adherence to standard infection control precautions in clinical and laboratory settings is essential for healthcare personnel.